Stability of vancomycin hydrochloride employed in antimicrobial seal solutions of central intravenous catheters
暂无分享,去创建一个
F. Fonseca | M. Peterlini | P. Rosa | M. Pedreira | P. Onofre | D. Barros
[1] L. Björkhem-Bergman,et al. Equal effect of vancomycin lock with or without heparin in treatment of central venous catheter related blood stream infections – an observational study in palliative home care , 2021, Infectious diseases.
[2] Lian Zhang,et al. Vancomycin-lock therapy for prevention of catheter-related bloodstream infection in very low body weight infants , 2020, BMC Pediatrics.
[3] A. Herranz-Alonso,et al. Standardization and Chemical Characterization of Intravenous Therapy in Adult Patients: A Step Further in Medication Safety , 2020, Drugs in R&D.
[4] R. Ford,et al. The microbial biofilm composition on peripherally inserted central catheters: A comparison of polyurethane and hydrophobic catheters collected from paediatric patients , 2020, The journal of vascular access.
[5] R. Faria,et al. Economic analysis of the prevalence and clinical and economic burden of medication error in England , 2020, BMJ Quality & Safety.
[6] J. Foushee,et al. Physical Compatibility of Medications Used in Critically Ill Patients with Balance Fluid Solutions. , 2020, International journal of pharmaceutical compounding.
[7] S. Aishwarya,et al. Intravenous Drug Incompatibilities in the Intensive Care Unit of a Tertiary Care Hospital in India: Are they Preventable? , 2020, Journal of research in pharmacy practice.
[8] S. Genay,et al. Evaluation of the stability of vancomycin solutions at concentrations used in clinical services. , 2020, European journal of hospital pharmacy : science and practice.
[9] E. Bouza,et al. Can vancomycin lock therapy extend the retention time of infected long‐term catheters? , 2020, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[10] Janine Clarke,et al. Incidence and prevalence of intravenous medication errors in the UK: a systematic review , 2018, European journal of hospital pharmacy : science and practice.
[11] M. Akash,et al. Chemical Kinetics and Its Applications in Drug Stability , 2020 .
[12] I. Imran,et al. Principles of Pharmaceutical Analysis in Drug Stability and Chemical Kinetics , 2020 .
[13] G. Roshandel,et al. Medication Errors and Their Relationship with Care Complexity and Work Dynamics , 2019, Open access Macedonian journal of medical sciences.
[14] C. McInnes,et al. Compatibility and Stability of Daptomycin Lock Solutions in Combination with Gentamicin, Azithromycin, Heparin and Trisodium Citrate , 2019 .
[15] S. Genay,et al. Clinical implications of intravenous drug incompatibilities in critically ill patients. , 2019, Anaesthesia, critical care & pain medicine.
[16] F. Qamar,et al. Clinical profile and outcome of antibiotic lock therapy for bloodstream infections in pediatric hematology/oncology patients in a tertiary care hospital, Karachi, Pakistan , 2019, International journal of pediatrics & adolescent medicine.
[17] V. Anttila. Central venous catheter care for children with cancer should focus on early infections , 2018, Acta paediatrica.
[18] S. Begum,et al. PHARMACEUTICAL INCOMPATIBILITES: A REVIEW , 2018, Asian Journal of Pharmaceutical Research and Development.
[19] V. Piriou,et al. Drug incompatibilities in intravenous therapy: evaluation and proposition of preventive tools in intensive care and hematology units , 2018, European Journal of Clinical Pharmacology.
[20] J. Bednar,et al. Antimicrobial efficiency and stability of two decontamination solutions , 2018, Cell and Tissue Banking.
[21] E. Abdala,et al. Role of Lock Therapy for Long-Term Catheter-Related Infections by Multidrug-Resistant Bacteria , 2018, Antimicrobial Agents and Chemotherapy.
[22] S. Gul,et al. Potential Drug–Drug Interactions with Antimicrobials in Hospitalized Patients: A Multicenter Point-Prevalence Study , 2018, Medical science monitor : international medical journal of experimental and clinical research.
[23] E. Troster,et al. Risk factors for vascular catheter-related bloodstream infections in pediatric intensive care units , 2018, Revista Brasileira de terapia intensiva.
[24] M. Ardura. Overview of Infections Complicating Pediatric Hematopoietic Cell Transplantation. , 2018, Infectious disease clinics of North America.
[25] Katri Vehviläinen-Julkunen,et al. Differences Between Methods of Detecting Medication Errors: A Secondary Analysis of Medication Administration Errors Using Incident Reports, the Global Trigger Tool Method, and Observations , 2016, Journal of patient safety.
[26] Sara E Cosgrove,et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[27] F. Burczynski,et al. Antibiotic‐Heparin Lock: In Vitro Antibiotic Stability Combined with Heparin in a Central Venous Catheter , 2000, Pharmacotherapy.
[28] W. Rusho,et al. Compatibility of commonly used bone marrow transplant drugs during Y-site delivery. , 1997, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[29] C L Rümke,et al. [Incidence and prevalence]. , 1983, Nederlands tijdschrift voor geneeskunde.
[30] A. Hirschfelder. THE UNITED STATES PHARMACOPEIAL CONVENTION , 1930 .